Search for: "Lambert v. State"
Results 101 - 120
of 601
Sort by Relevance
|
Sort by Date
29 Dec 2018, 2:17 am
| The IP term (thus far) of the millennium: the curious story of the adoption of "patent troll" and "internet trolling" | No pain, no gain: Plausibility in Warner-Lambert v Actavis | Testing the boundaries of subjectivity: Infringement of Swiss-type claims in Warner-Lambert v Actavis | Is SPINNING generic? [read post]
20 Dec 2018, 6:27 am
In the wake of the UK Supreme Court decision in Warner-Lambert v Actavis (IPKat post here), second medical use claims have received considerable attention from the IP commentariat. [read post]
19 Dec 2018, 9:49 am
PatentsKat Neil reflects on the lexical transformation of the “troll” from stock character in Scandinavian mythology (and plastic dolls with bright colored up-combed hair...) into a staple of contemporary IP discourse, not once but twice: The IP term (thus far) of the millennium: the curious story of the adoption of "patent troll" and "internet trolling"Kat Troll DollIPKat provided further depth commentary on Warner-Lambert v Actavis, delving… [read post]
11 Dec 2018, 4:00 am
The justices also issued one opinion yesterday: In United States v. [read post]
29 Nov 2018, 5:00 am
Lambert: The case involves when the doctrine of equitable tolling should apply. [read post]
29 Nov 2018, 4:08 am
Lambert, which involves the timeliness of an appeal from a denial of class-action certification. [read post]
28 Nov 2018, 8:17 am
Which makes sense, given stated concerns for Martian invasions. [read post]
28 Nov 2018, 8:12 am
Anyone who believes civil procedure is not funny should read the transcript of Tuesday’s argument in Nutraceutical Corp. v. [read post]
28 Nov 2018, 7:50 am
The second case, Carpenter v. [read post]
27 Nov 2018, 4:01 am
Lambert, which involves the timeliness of an appeal from a denial of class-action certification. [read post]
26 Nov 2018, 11:16 pm
Infringement of Claim 3 The focus of the infringement ruling is Claim 3, stating --“use of pregabalin for the preparation of a pharmaceutical composition for treating neuropathic pain”.The claim in question is a purpose-limited process claim. [read post]
26 Nov 2018, 1:48 am
The dust has started to settle following the Supreme Court decision in Warner-Lambert v Actavis [2018] UKSC 56 handed down recently (IPKat post here). [read post]
20 Nov 2018, 7:15 am
That possibility is the focus of Nutraceutical Corp. v. [read post]
14 Nov 2018, 3:25 am
In Regeneron v Kymab (IPKat post here), a patent was found enabled and thus sufficiently disclosed despite the example methods provided in the specification being unworkable at the time of the invention. [read post]
12 Nov 2018, 1:00 am
Warner-Lambert Company LLC v Generics (UK) Ltd t/a Mylan & Anor, heard 12-15 Feb 2018. [read post]
5 Nov 2018, 1:00 am
Warner-Lambert Company LLC v Generics (UK) Ltd t/a Mylan & Anor, heard 12-15 Feb 2018. [read post]
29 Oct 2018, 2:00 am
Warner-Lambert Company LLC v Generics (UK) Ltd t/a Mylan & Anor, heard 12-15 Feb 2018. [read post]
22 Oct 2018, 1:00 am
Warner-Lambert Company LLC v Generics (UK) Ltd t/a Mylan & Anor, heard 12-15 Feb 2018. [read post]
15 Oct 2018, 7:05 am
Nieves v. [read post]
15 Oct 2018, 1:00 am
Warner-Lambert Company LLC v Generics (UK) Ltd t/a Mylan & Anor, heard 12-15 Feb 2018. [read post]
